相关实验视频
Updated: Jul 18, 2025

09:05
MicroRNA-based Regulation of Picornavirus Tropism
Published on: February 6, 2017
7.6K
微RNA-9-1通过向tankyrase 1减弱流感A病毒复制
Gayan Bamunuarachchi1,2, Kishore Vaddadi1,2, Xiaoyun Yang1,2
1Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, Oklahoma, USA.
Journal of innate immunity
|August 22, 2023
概括
这项研究表明,miR-9-1,一种抗流感微RNA,向tankyrase 1 (TNKS1) 抑制流感A病毒复制并增强细胞抗病毒状态.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 流感A型病毒 (IAV) 对抗病毒药物的耐药性需要新的治疗点.
- 对于病毒复制至关重要的宿主因素是新的抗病毒疗法的潜在目标.
研究的目的:
- 调查坦基酶1 (TNKS1) 和miR-9-1在IAV感染中的作用.
- 探索针对新型抗病毒策略的TNKS1和miR-9-1的潜力.
主要方法:
- 在IAV感染的人类肺上皮细胞和小鼠肺部评估TNKS1表达.
- 利用RNA干扰对TNKS1进行淘汰,并评估其对病毒复制的影响.
- 雇佣的TNKS1 3'-非翻译区域 (3'-UTR) 报告员测试以确定向的微RNA.
- 在肺上皮细胞和小鼠肺部过度表达的miR-9-1,以评估其抗病毒作用.
- 测量病毒mRNA,蛋白质水平和病毒产量,以量化复制.
主要成果:
- 在IAV感染的细胞和组织中观察到TNKS1表达的增加.
- TNKS1的淘汰显著抑制了流感病毒的复制.
- 鉴定出miR-9-1是一种针对TNKS1.1的微RNA.
- 过度表达miR-9-1减少了病毒复制,诱导了I型干扰素的产生,并增强了STAT1酸化.
- 在小鼠肺部中miR-9-1的宫外表达抑制了病毒复制,并降低了对IAV感染的易感性.
结论:
- miR-9-1通过准TNKS1.1,作为一种抗流感微RNA.
- miR-9-1通过I型干扰素诱导和STAT1激活来增强细胞抗病毒状态.
- 准miR-9-1/TNKS1轴为开发新型流感抗病毒疗法提供了一个有希望的战略.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K

